The Bottom Line

Discoid lupus erythematosus (DLE) is an autoimmune skin condition that can destroy hair follicles on the scalp, causing permanent bald patches. About 50–80% of people with scalp DLE develop hair loss. The damage cannot be reversed once scarring occurs — but treatment started early can stop the disease from spreading. If you have unexplained scalp sores, redness, or hair loss that is not improving, see a dermatologist promptly.

What Is Discoid Lupus Erythematosus?

Discoid lupus erythematosus (DLE) is the most common skin form of lupus. Unlike systemic lupus (SLE), which affects the whole body including organs, DLE usually stays confined to the skin — most often the scalp, face, and ears. In DLE, the immune system mistakenly attacks the skin and hair follicles, causing chronic inflammation and eventual scarring.

About 5–10% of people with localized DLE eventually develop signs of systemic lupus during long-term follow-up, which is why ongoing monitoring is important even when the disease appears limited to the skin.

What Does It Look Like on the Scalp?

Scalp DLE typically appears as red or purplish, raised patches with a thick, adherent scale. As the disease progresses:

  • The center of each patch becomes pale, scarred, and atrophic (shrunken)
  • Hair follicles get plugged, creating a pattern called "carpet-tack" sign — where removing a scale reveals spiky projections from the underside
  • Hair is permanently lost from scarred areas, since destroyed follicles cannot regrow
  • Active lesions at the edge of the patch are red and expanding, while the center is pale and inactive

About half of people with scalp DLE also report burning, itching, tenderness, or pain at affected areas.

Why Does It Cause Permanent Hair Loss?

In DLE, T-lymphocytes (a type of white blood cell) attack the base of the skin cells and hair follicle structures. The resulting inflammation destroys the follicle from the inside. Once a follicle is destroyed and replaced by scar tissue, it cannot produce hair again. This is what makes DLE a "scarring alopecia" — unlike conditions such as alopecia areata, where the follicle remains intact and regrowth is possible.

UV light exposure can trigger flares, which is why the scalp — often in the sun — is so commonly affected.

How Is It Diagnosed?

Your dermatologist will likely perform a scalp biopsy, which is the gold standard for diagnosis. The biopsy shows a characteristic pattern called interface dermatitis — inflammation at the boundary between the outer and inner skin layers — along with a heavy infiltrate of lymphocytes around the follicles.

Additional tests often include:

  • Antinuclear antibody (ANA) test — positive in 50–80% of DLE patients
  • Anti-Ro/SSA and anti-La/SSB antibodies — present in 30–50%
  • Dermoscopy showing follicular plugging, surrounding redness, and absence of fine vellus hairs in scarred areas
  • Blood tests to rule out systemic lupus involvement (kidneys, blood counts, etc.)

Treatment Options

Treatment aims to stop active inflammation and prevent further follicle destruction. Hair that has already been lost from scarred areas cannot be recovered.

First-line treatments

  • Potent topical steroids (e.g., betamethasone dipropionate 0.05% or fluocinonide 0.05%, applied twice daily) reduce inflammation in active patches
  • Intralesional triamcinolone acetonide (2.5–5 mg/mL injected monthly into active lesions) — approximately 60–70% of patients show disease stabilization or improvement with this approach
  • Topical tacrolimus 0.1% — a steroid-sparing option applied twice daily for maintenance

Systemic treatments

  • Hydroxychloroquine (Plaquenil, 200–400 mg daily) is the most widely used oral treatment. It suppresses the immune response that drives DLE and reduces UV sensitivity. About 40–50% of patients achieve good control with topical treatment plus hydroxychloroquine.
  • Quinacrine added to hydroxychloroquine may improve response in resistant cases
  • Oral retinoids (acitretin or isotretinoin) for cases not responding to antimalarials
  • Dapsone, mycophenolate mofetil, or thalidomide for severe or refractory disease

Sun protection

Daily broad-spectrum sunscreen (SPF 50+) and protective clothing are essential. UV exposure triggers flares, so sun protection is a core part of managing DLE — not optional.

When to See a Dermatologist

  • You have persistent red or scaly patches on your scalp that are not responding to dandruff shampoos
  • You are losing hair in patches, especially with redness or scarring at the edges
  • Patches are spreading or becoming more numerous
  • You have a known lupus diagnosis and develop new scalp symptoms
  • You are experiencing scalp burning, pain, or tenderness alongside hair loss
  • You notice scalp changes after sun exposure

Frequently Asked Questions

Can the hair grow back after DLE?

In areas where the follicles have been permanently scarred, no — hair cannot regrow. This is why early treatment is so important. If inflammation is caught and controlled before scarring occurs, further hair loss can be prevented, but what has already been lost to scarring is permanent.

Is discoid lupus the same as systemic lupus?

No, they are related but different. DLE is primarily a skin condition. Systemic lupus (SLE) affects internal organs like the kidneys, joints, and blood cells. However, about 5–10% of people with DLE eventually develop systemic involvement, so ongoing medical monitoring is recommended.

Do I need to avoid the sun?

Yes — UV light is a known trigger for DLE flares. Daily use of SPF 50+ sunscreen, protective hats, and limiting midday sun exposure are strongly recommended. This is one of the most important steps you can take to reduce disease activity.

How long will I need to take hydroxychloroquine?

DLE is a chronic condition, and many patients require long-term treatment with hydroxychloroquine. Your dermatologist will periodically review whether the medication is still needed. Annual eye exams are recommended for people on long-term hydroxychloroquine to monitor for rare retinal side effects.

References

  1. Costner MI, Sontheimer RD. Lupus erythematosus. In: Wolff K, et al., eds. Fitzpatrick's Dermatology in General Medicine. 8th ed. McGraw-Hill; 2012.
  2. Kuhn A, et al. Cutaneous lupus erythematosus: update of therapeutic options Part I and II. J Am Acad Dermatol. 2011;65(6):e179–e193.
  3. Fabbri P, et al. Scarring alopecia. J Eur Acad Dermatol Venereol. 2004;18(4):381–392.
  4. Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev. 2005;4(5):296–302.
  5. Chang AY, et al. Cutaneous lupus erythematosus: epidemiology and clinical manifestations in a cohort. Arthritis Care Res. 2011;63(9):1360–1366.

Trusted Resources

Always consult a board-certified dermatologist for diagnosis and personalized treatment recommendations. Lupus requires coordinated care and may involve rheumatology consultation.